Impact factors (IFs) are published each year by Clarivate Analytics, a company providing multiple products pertaining to scientific research insights. Impact factors reflect a journal’s performance and status through a record of how often its articles are cited in other biomedical journals. The release of IF data is eagerly awaited each year by publishers and editorial teams. The data released last month ranked journals with respect to citations during 2024 of articles published during 2022-2023.
The IF for Pharmacotherapy increased to 3.4, placing the journal in the top one-third of all journals in the Pharmacy and Pharmacology category. The IF for the Journal of the American College of Clinical Pharmacy (JACCP) increased to 1.5 and continues to grow in submissions and reach.
The IF should not be the sole measure of journal quality, but it remains a vital measure in biomedical publishing of a journal’s impact on its field. The journal’s citation metrics alongside data on downloads, international readership, and comparisons with other journals are all measures of its success.
ACCP journal publication is made possible through the combined efforts of many individuals, including publication staff, editors, editorial board members, and reviewers. Most important are the authors who choose to submit their best work to the official journals of ACCP, Pharmacotherapy and JACCP.
Included among the top articles published in 2022-2023 with the most citations in 2024 are the following.
Pharmacotherapy
Nelson J, Alvey N, Bowman L, et al. Consensus recommendations for use of maintenance immunosuppression in solid organ transplantation: Endorsed by the American College of Clinical Pharmacy, American Society of Transplantation, and the International Society for Heart and Lung Transplantation. Pharmacotherapy. 2022;42(8):599-633. https://doi.org/10.1002/phar.2716
Strawn JR, Mills JA, Poweleit EA, Ramsey LB, Croarkin PE. Adverse effects of antidepressant medications and their management in children and adolescents. Pharmacotherapy. 2023;43(7):675-690. https://doi.org/10.1002/phar.2767
McCreary EK, Davis MR, Narayanan N, et al. Utility of triazole antifungal therapeutic drug monitoring: insights from the Society of Infectious Diseases Pharmacists. Pharmacotherapy. 2023;43(10):1043-1050. https://doi.org/10.1002/phar.2850
Hong LT, Downes KJ, Fakhri Ravari A, et al. International consensus recommendations for the use of prolonged-infusion beta-lactam antibiotics: Endorsed by the American College of Clinical Pharmacy, British Society for Antimicrobial Chemotherapy, Cystic Fibrosis Foundation, European Society of Clinical Microbiology and Infectious Diseases, Infectious Diseases Society of America, Society of Critical Care Medicine, and Society of Infectious Diseases Pharmacists. Pharmacotherapy. 2023;43(8):740-777. https://doi.org/10.1002/phar.2842
Bidell MR, Hobbs ALV, Lodise TP. Gut microbiome health and dysbiosis: a clinical primer. Pharmacotherapy. 2022;42(11):849-857. https://doi.org/10.1002/phar.2731
JACCP
Rech MA, Jones GM, Naseman RW, Beavers C. Premature attrition of clinical pharmacists: call to attention, action, and potential solutions. J Am Coll Clin Pharm. 2022;5(7):689‐696. https://doi.org/10.1002/jac5.1631
Shah KK, Touchette DR, Marrs JC. Research and scholarly methods: measuring medication adherence. J Am Coll Clin Pharm. 2023;6(4):416‐426. https://doi.org/10.1002/jac5.1771
Bondi DS, Acquisto NM, Buckley MS, et al. Rewards, recognition, and advancement for clinical pharmacists. J Am Coll Clin Pharm. 2023;6(4):427‐439. https://doi.org/10.1002/jac5.1775
American College of Clinical Pharmacy. Standards of practice for clinical pharmacists. J Am Coll Clin Pharm. 2023;6(10):1156‐1159. https://doi.org/10.1002/jac5.1873
Cernasev A, Axon DR. Research and scholarly methods: thematic analysis. J Am Coll Clin Pharm. 2023;6(7):751‐755. https://doi.org/10.1002/jac5.1817
Reed BN. Turning the tide: addressing threats to pharmacist well-being through work redesign. J Am Coll Clin Pharm. 2023;6(7):742‐750. https://doi.org/10.1002/jac5.1831